Immunotherapy with Mycobacterium vaccae in the treatment of psoriasis

FEMS Immunology and Medical Microbiology

Volumn 21, Issue 1, 1998, Pages 71-77

  Lehrer, Amira ^a   Bressanelli, Amalia ^a   Wachsmann, Viviana ^a   Bottasso, Oscar ^b   Bay, Maria Luisa ^b   Singh, Mahavir ^c   Stanford, Cynthia ^d   Stanford, John ^d  

^a Hospital Provincial de Rosario   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Etiology; Immunotherapy; Mycobacterium vaccae; Psoriasis

Indexed keywords

CONCANAVALIN A; MYCOBACTERIUM ANTIGEN; PLACEBO; TETANUS TOXOID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNOTHERAPY; INTRADERMAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MYCOBACTERIUM VACCAE; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031836413     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(98)00035-2     Document Type: Article

References (19)

1. Gottlieb, A.B. (1990) Immunologic mechanisms in psoriasis. J. Invest. Dermatol. 95 (Suppl.), 18S-19S.
2. Wong, R.L., Winslow, C.M. and Cooper, K.D. (1993) The mechanisms of action of cyclosporin A in the treatment of psoriasis. Immunol. Today 14, 69-74.
3. Bata Csorgo, Z., Hammerberg, C., Voorhees, J.J. and Cooper, K.D. (1995) Intralesional T lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J. Invest. Dermatol. 105 (Suppl.), 89S-94S.
4. Farber, E.M. and Nall, L. (1991) Epidemiology: natural history and genetics. In: Psoriasis, 2nd edn. (Roenigk, H.H. and Maibach, H.I., Eds.), pp. 209-258. Marcel Dekker, New York.
5. Krueger, G.G. and Duvic, M. (1994) Epidemiology of psoriasis: clinical issues. J. Invest. Dermatol. 102, 14S-18S.
6. Valdimarsson, H., Baker, B.S., Powles, A. and Fry, L. (1995) Psoriasis: a T cell mediated autoimmune disease induced by streptococcal superantigens? Immunol. Today 16, 145-149.
7. Leung, D.Y.M., Travers, J.B. and Norris, D.A. (1995) The role of superantigens in skin disease. J. Invest. Dermatol. 105, 37S-42S.
8. Bay, M.L., Lehrer, A., Bressanelli, A., Morini, J.C., Bottasso, O.A. and Stanford, J.L. (1998) Psoriasis patients have T-cells with reduced responsiveness to common mycobacterial antigens. FEMS Immunol. Med. Microbiol. 21, 65-70.
9. Ramu, G., Prema, G.D., Balakrishnan, S., Shanker Narayan, N.P. and Stanford, J.L. (1990) A preliminary report on the immunotherapy of psoriasis. Indian Med. Gazette 124, 381-382.
10. Rambukkana, A., Das, P.K., Witkamp, L., Yong, S., Meinardi, M.M.H.M. and Bos, J.D. (1993) Antibodies to mycobacterial 65-kDa heat shock protein and other immunodominant antigens in patients with psoriasis. J. Invest. Dermatol. 100, 87-92.
11. Fredriksson, T. and Pettersson, U. (1978) Severe psoriasis -oral therapy with a new retinoid. Dermatologica 157, 238-244.
12. Hernandez Munoz, H.E. and Stanford, J.L. (1996) IgA and IgG antibodies to distinct serotypes of Mycobacterium avium in HIV seropositivity and AIDS. J. Med. Microbiol. 44, 165-169.
13. Berger, S., Ballo, H. and Stutte, H.J. (1996) Distinct antigen-induced cytokine pattern upon stimulation with antibody complexed antigen consistent with a Th1 → Th2 shift. Res. Virol. 147, 103-108.
14. Bahr, G.M., Shaaban, M.A., Gabriel, M., Al Shimali, B., Siddiqui, Z., Chugh, T.G., Denath, F.M., Shahin, A., Behbehani, K., Chedid, L., Rook, G.A.W. and Stanford, J.L. (1990) Improved immunotherapy for pulmonary tuberculosis with Mycobacterium vaccae. Tubercle 71, 259-266.
15. Young, D.B. (1992) Heat-shock proteins: immunity and autoimmunity. Curr. Opin. Immunol. 4, 396-400.
16. Stanford, J.L. (1994) The history and future of vaccination and immunotherapy for leprosy. Trop. Geogr. Med. 46, 93-107.
17. Mukherjee, M., De Benedictis, C., Jewitt, D. and Kakkar, V.V. (1996) Association of antibodies to heat-shock protein-65 with percutaneous transluminal angioplasty and subsequent restenosis. Thromb. Haemost. 75, 258-260.
18. Nickoloff, B.J., Karabin, G.D., Barker, J.N.W.N. et al. (1991) Cellular localization of IL 8, and its inducer, tumor necrosis factor alpha in psoriasis. Am. J. Pathol. 138, 129-140.
19. Ettehadi, P., Greaves, M.W., Wallach, D., Aderka, D. and Camp, R.D.R. (1994) Elevated tumor necrosis factor alpha (TNFα) biological activity in psoriatic skin lesions. Clin. Exp. Immunol. 96, 146-151.